Involvement of the cyclic AMP system in the switch from tolerance into supersensitivity to the antinociceptive effect of the opioid sufentanil

British Journal of Pharmacology

Volumn 130, Issue 1, 2000, Pages 174-180

  Hurlé, María A ^a   Goirigolzarri, Isabel ^a   Valdizán, Elsa M ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Calcium channel blockers; Cyclic AMP; Opioids; Supersensitivity; Tolerance

Indexed keywords

ADENYLATE CYCLASE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC AMP; FORSKOLIN; FURALDIPINE; NALOXONE; NIMODIPINE; OPIATE; SUFENTANIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TOLERANCE; MALE; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

EID: 0034104329     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703304     Document Type: Article

References (46)

1. ALFARO, M.J., COLADO, M.I., LÓPEZ, F. & MARTÍN, M.I. (1990). Effect of clonidine, nimodipine and diltiazem on the in vitro opioid withdrawal response in the guinea-pig ileum. Br. J. Pharmacol., 101, 958-960.
2. ANTKIEWICZ-MICHALUK, L., MICHALUK, J., ROMANSKA, I. & VETULANI, J. (1990). Cortical dihydropyridine binding sites and behavioural syndrome in morphine-abstinent rats. Eur. J. Pharmacol., 180, 129-135.
3. ANTKIEWICZ-MICHALUK, L., MICHALUK, J., ROMÁNSKA, I. & VENTULANI, J. (1993). Reduction of morphine dependence and potentiation of analgesia by chronic co-administration of nifedipine. Psychopharmacol., 111, 457-464.
4. 2+ channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats. Eur. J. Pharmacol., 137, 9-13.
5. 2+ channel blockers and stimulants on morphine withdrawal in vitro. Eur. J. Pharmacol., 152, 175-178.
6. BLENDY, J.A. & MALDONADO, R. (1998). Genetic analysis of drug addiction: the role of cAMP response element binding protein. J. Mol. Med., 76, 104-110.
7. BONGIANI, F., CARLA, V., MORONI, F. & PELLEGRINI-GIAMPIETRO, D.E. (1986). Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats. Br. J. Pharmacol., 88, 561-567.
8. BOT, G., BLAKE, A.D., LI, S. & REISINE, T. (1998). Fentanyl and its analogs sesensitize the cloned mu opioid receptor. J. Pharmacol. Exp. Ther., 285, 1207-1218.
9. BURKEY, A.R., CARSTENS, E., WENNIGER, J.J., TANG, J. & JASMIN, L. (1996). An opioidergic cortical antinociception triggering site in the agranular insular cortex of the rat contributes to morphine antinociception. J. Neurosci., 16, 6612-6623.
10. BUSHNELL, M.C., DUNCAN, G.H., HOFBAUER, R.K., HA, B., CHEN, J.I. & CARRIER, B. (1999). Pain perception: is there a role for primary somatosensory cortex? Proc. Natl., Acad, Sci. U.S.A., 96, 7705-7709.
11. COOPER, D.M.F., MONS, N. & KARPEN, J.W. (1995). Adenylyl cyclases and the interaction between calcium and cyclic AMP signalling. Nature, 374, 421-424.
12. COX, B.M. (1993). Opioid receptor-G protein interactions: acute and chronic effects of opioids. In Hdb. Exp. Pharmacol.: Opioids. ed. Herz, A., Akil, H., Simon, E. pp 145-188 Berlin: Springer-Verlag.
13. CHAKRABARTI, S., LAW, P-Y & LOH, H.H. (1995). Neuroblastoma Neuro 2A cells stably expressing a cloned μ-opioid receptor: a specific cellular model to study acute and chronic effects of morphine. Mol. Brain Res., 30, 269-278.
14. CHILDERS, S.R. (1993). Opioid receptor coupled second messenger systems. In Hdb. Exp. Pharmacol.: Opioids ed.: Herz, A., Akil, H. & Simon, E. pp: 145-188. Berlin: Springer-Verlag.
15. D'ARMOUR, F.E. & SMITH, D.L. (1941). A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther., 72, 74-79.
16. DÍAZ, A., RUIZ, F., FLÓREZ, J., HURLÉ, M.A. & PAZOS, A. (1995a). Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system. J. Pharmacol. Exp. Ther., 274, 1552-1561.
17. ++ channels during opioid tolerance and supersensitivity in rats. J. Pharmacol. Exp. Ther., 274, 1545-1551.
18. DIERSSEN, M., FLÓREZ, J. & HURLÉ, M.A. (1990) Calcium channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions. Naunyn-Schmidebergs's Arch. Pharmacol., 342, 559-565.
19. DUMAN, R.S., TALLMAN, J.F. & NESTLER, E.J. (1988). Acute and chronic opiate-regulation of adenylyl cyclase in brain: specific effects in locus coeruleus. J. Pharmacol. Exp. Ther., 246, 1033-1039.
20. ERIKSSON, P.S., CARLSSON, B., ISAKSSON, E. & RONNBACK, L. (1992). Altered amounts of G-protein mRNA and cyclic AMP accumulation after long-term opioid receptor stimulation of neurones in primary culture from the rat cerebral cortex. Brain Res. Mol. Brain Res., 14, 317-325.
21. HARDINGHAM, G.E., CHAWLA, S., JOHNSON, C.M. & BADING, H. (1997). Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature, 385, 260-265.
22. HU, S.C., CHRIVIA, J. & GHOSH A. (1999). Regulation of CBP-mediated transcription by neural calcium signalling. Neuron, 22, 799-808.
23. KALLIOMAKI, J., LUO, X.L., YU, Y.B. & SCHOUENBORG, J. (1998). Intrathecally applied morphine inhibits nociceptive C fibre input to the primary somatosensory cortex (SI) of the rat. Pain, 77, 323-329.
24. KHARKEVICH, D.A. & CHURUKANOV, V.V. (1999). Pharmacological regulation of descending cortical control of the nociceptive processing. Eur. J. Pharmacol., 375, 121-131.
25. KRYSTAL, J.H., COMPERE, S., NESTLER, E.J. & RASMUSSEN, K. (1996). Nimodipine can reduce naloxone-precipitated locus coeruleus activation and abstinence behaviour in morphine-dependent rats. Physiol. Behav., 59, 863-866.
26. LOWRY, O.H , ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with Polin phenol reagent. J. Biol. Chem., 193, 265-275.
27. MALDONADO, R., BLENDY, J.A., TZAVARA, E., GASS, P., ROQUES, B.P. & HANOUNE, J. ( 1996). Reduction of morphine abstinence in mice with a mutation of the gene encoding CREB. Science, 273, 657-659.
28. MALDONADO, R., VALVERDE, O., GARBAY, C. & ROQUES, B.P. (1995). Protein kinases in the locus coeruleus and periaqueduetal gray matter are involved in the expression of opiate withdrawal. Naunyn-Schmidebergs's Arch. Pharmacol., 352, 565-575.
29. 2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat. Eur. J. Pharmacol., 352, 189-197.
30. NESTLER, E.J. (1996). Under siege: The brain on opiates. Neuron. 16, 897-900.
31. 3H-nitrendipine binding to synaptic membranes: Similarity with morphine tolerance. Naunyn-Schmidebergs's Arch. Pharmacol., 341, 123-127.
32. 3H-noradrenaline release. Br. J. Pharmacol., 93, 535-540.
33. PUTTFARCKEN, P.S., WERLING, L.L. & COX, B.M. (1988). Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: A useful model for the study of tolerance at μ opioid receptors. Mol. Pharmacol., 33, 520-527.
34. RAMKUMAR, V. & EL-FAKAHANY, E.E. (1988). Prolonged morphine treatment increases rat brain dihydropyridine binding sites: Possible involvement in development of morphine dependence. Eur. J. Pharmacol., 146, 73-83.
35. SANTILLÁN, R., HURLÉ, M.A., ARMIJO, J.A., DE LOS MOZOS, R. & FLÓREZ, J. (1998). Nimodipine-enhanced opiate analgesia in cancer patients requiring morphine dose escalation: A double blind, placebo-controlled study. Pain, 76, 17-26.
36. SANTILLÁN. R., MAESTRE. J.M., HURLÉ, M.A. & FLÓREZ, J. (1994). Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine A preliminary report. Pain. 58, 129-132.
37. SOTO-MOYANO, R., GALVEZ, J., VALLEJOS, C. & HERNANDEZ, A. (1988). Topical application of morphine to the rat somatosensory cortex produces analgesia to tonic pain. J. Neurosci Res., 19, 511-514.
38. SUNAHARA, R.K., DESSAUER, C. & GILMAN, A.G. (1996). Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol., 36, 461-480.
39. SUTKOWSKi, E.M., ROBBINS, J.D., TANG, W-J. & SEAMON, K.B. (1996). Irreversible inhibition of forskolin interactions with type I adenylyl cyclase by a 6-isothiocyanate derivative of forskolin. Mol. Pharmacol., 50, 299-305.
40. TALBOT, J.D., MARKET, S., EVANS, A.C., MEYER, E., BUSHNELL, M.C. & DUNCAN, G.H. (1991). Multiple representations of pain in human cerebral cortex. Science, 251, 1355-1358.
41. TERWILLIGER, R.Z., BEITNER-JOHNSON, D., SEVARINO, K.A., CRAIN, S.M. & NESTLER, E.J. (1991). A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res., 548, 100-110.
42. TREEDE, R-D., KENSHALO, D.R., GRACELY, R.H. & JONES, A.K.P. (1999). The cortical representation of pain. Pain, 79, 105-111.
43. VALVERDE, O., TZAVARA, E., HANOUNE, J., ROQUES, B.P. & MALDONADO, R. (1996). Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal. Eur. J. Neurosci., 8, 2671-2678.
44. YU, H.J., MA, H. & GREEN, R.D. (1993). Calcium entry via L-type calcium channels acts as a negative regulator of adenylyl cyclase activity and cyclic AMP levels in cardiac myocytes. Mol. Pharmacol., 44, 689-693.
45. ZHARKOVSKY, A., KATAJAMAKI, J., SEPPALA, T. & AHTEE, L. (1999). Morphine-induced analgesia in rats withdrawn from concurrent nimodipine and morphine treatment. Pain; 79, 217 222.
46. ZHARKOVSKY, A., TÖTTERMAN, A.M., MOISIO, J. & ATHEE, L. (1993). Concurrent nimodipine attenuates the withdrawal signs and the increase of dihydropyridine binding after chronic morphine treatment in rats. Naunyn-Sclmiedeberg's Arch. Pharmacol., 347, 483-486.